Express News | Guangdong Zhongsheng Pharmaceutical: Received the "Pharmaceutical Registration Certificate" for Bromonidine Tartrate Eye Drops.

BreakingsJan 14 15:54

A-shares fluctuated丨The Concept of influenza continues to weaken, Shandong Lukang Pharmaceutical dropped over 7%, and the Chinese Center for Disease Control and Prevention stated that the positive rate of influenza virus has recently shown a tendency to s

On January 10, according to Gelonghui, A-share flu concept stocks continue to adjust. Among them, Shandong Lukang Pharmaceutical fell over 7%, Shanghai Kaibao Pharmaceutical dropped over 6%, Xiangxue Pharmaceutical decreased by 4.6%, and Guangdong Zhongsheng Pharmaceutical, Shanghai Kehua Bio-engineering, Dirui Industrial, and Hunan Er-kang Pharmaceutical also fell. In news, the China Center for Disease Control and Prevention released the latest situation on national sentinel surveillance of acute respiratory infectious diseases. The recent positive rate of influenza virus has slowed down, and it is expected that the level of influenza activity will gradually decline in mid to late January, with different levels of influenza activity in various provinces. Among them, the positive rates of rhinovirus, adenovirus, and mycoplasma pneumonia continue to decline. Other respiratory pathogens, such as the novel coronavirus, remain at a low epidemic level.

Gelonghui FinanceJan 10 11:06

Guangdong Zhongsheng Pharmaceutical (002317.SZ): Its core products are mainly suitable for the treatment of chronic diseases in the elderly.

On January 9, Gelonghui reported that Guangdong Zhongsheng Pharmaceutical (002317.SZ) stated on the investor interaction platform that the company's core products are mostly suitable for the treatment of chronic diseases in the elderly, such as Compound Thrombus Capsule, Cerebral Thrombus Capsule, and Compound Danshen Tablets, among others. The company has partnered with major chain pharmacies to launch the "Caring for the Silver Age•Health for All" project, forming a product package for chronic diseases that combines Compound Thrombus Capsule, Cerebral Thrombus Capsule, and other featured products. The aim is to provide services including testing, patient education, and medication guidance for common diseases in the elderly, empowering county-level chain pharmacies to improve the service system for the elderly with higher quality products and more professional support.

Gelonghui FinanceJan 9 16:46

Guangdong Zhongsheng Pharmaceutical (002317): Innovative Drugs have entered the realization phase with stable development in traditional Business.

Core logic: The company has entered the phase of delivering its Innovative Drugs layout. There is a bullish outlook on the sales ramp-up after the approval and market launch of the influenza drug Anladiwei, and optimism regarding the overseas licensing potential of GLP-1R/GIPR dual-target weight loss and blood sugar reduction drugs. Weight loss/blood sugar reduction drugs: GLP-

Guotou SecuritiesJan 8 07:37

A-shares show unusual activity丨Traditional Chinese Medicine stocks all rose, with Guangdong Zhongsheng Pharmaceutical and several other stocks hitting the daily limit, as the State Council emphasized increasing support for the research and innovation of T

On January 6, in the A-share market, the Traditional Chinese Medicine Sector rose against the trend, with Datang Pharmaceutical rising nearly 19%, Shanghai Kaibao Pharmaceutical rising over 16%, Xiangxue Pharmaceutical rising over 14%, Henan Taloph Pharmaceutical Stock, Shijiazhuang Yiling Pharmaceutical, Hainan Huluwa Pharmaceutical Group, and Guangdong Zhongsheng Pharmaceutical hitting the 10% limit up, Shanghai Shenqi Pharmaceutical Investment Management rising 9%, Jinghua Pharmaceutical Group, Tianjin Chase Sun Pharmaceutical, and Jiangxi Wannianqing Cement rising over 8%, Guizhou Sanli Pharmaceutical Co.,Ltd., Biovalley, and Guizhou Xinbang Pharmaceutical rising over 7%, Shandong Wohua Pharmaceutical and Sunflower Pharmaceutical Group rising over 6%, Zhejiang Xinguang Pharmaceutical, Oukang Pharmaceutical, Gansu Longshenrongfa Pharmaceutical Industry, and Guilin Sanjin Pharmaceutical rising over 5%, Guiyang Xintian Pharmaceutical, Zhejiang Wecome Pharmaceutical, Chongqing Taiji Industry, and Hubei Jumpca

Gelonghui FinanceJan 6 15:20

Express News | The flu Concept is active at the beginning of trading, Shandong Lukang Pharmaceutical has two consecutive limit ups.

BreakingsJan 6 09:26